<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180603039968N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-10-10</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Patient Preparation by Multimedia Method on Anxiety, Pain, and Consumption of analgesic after Vitrectomy surgery.</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Patient Preparation by Multimedia Method on Anxiety, Pain, and Consumption of analgesic after Vitrectomy surgery.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/31745</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Randomization method: block
Each block represents a week.
Each block size is equivalent to 4 days of a week when vitrectomy surgeries are conducted.
The days when the vitrectomy surgery is conducted:Sunday, Monday, Tuesday and Thursday
In this method, the study group is named as group A and the control group is named as group B.
According to the existing conditions, 6 blocks are likely to be as follows:
1-AABB
2- ABAB
3 ABBA
4- BBAA
5- BAAB
6- BABA
Selection of blocks is random and based on the cards' shuffling.
By selecting each card, the samples are respectively placed in the control or study groups, Blinding description: • In order to blindness in the study, researchers and statistical advisers will be unaware of the allocation of patients in the control or intervention group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Anxiety; Pain; Retinal detachment;vitrectomy؛ Preoperative preparation; Multimedia education.</hc_freetext>
      <i_freetext>Intervention 1: Study group: After selecting the block, the allocation of patients to the study group is determined. On the night before the surgery, by considering the entry requirements of the study, and after having effective communication and gaining patient's trust, we will start to explain the process to the patient, gain his/her satisfaction and describe the research goals. Patient information is also recorded and the Spielberger questionnaire is filled in. Patients receive routine medical and nursing care according to the hospital policies. Afterward, some didactic photographs and videos will be shown to the patient by using a tablet, and his/her oral questions will be answered. The investigator explains to the patient about non-pharmacological pain control methods as the complementary of pharmacological therapies. In the next step, 30 minutes before entering the operating room, patient's information is recorded and the Spielberger questionnaire is filled in. All patients undergo the general anesthesia. After surgery, at intervals before entering the department, and 1, 2, 3, and 4 hours after entering the department, the level of pain and consumption of pain killers will be measured. Intervention 2: Control group: After selecting the block, the allocation of patients to the control group will be determined. On the night before the operation, by considering the entry requirements of the study, after describing the process and gaining satisfaction of the patient, the patient's information will be recorded and the Spielberger questionnaire will be filled in. the control group's patients will receive routine medical and nursing care according to hospital policies. In the next step, 30 minutes before entering the operating room, patient's information is recorded and the Spielberger questionnaire is filled in. All patients undergo the general anesthesia. After surgery, at intervals before entering the department, and 1, 2, 3, and 4 hours after entering the department, the level of pain and consumption of pain killers will be measured.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Mean of anxiety score, mean of pain anxiety score, mean of blood pressure, mean of consumption of analgesic

When:
6 months after printing results

To whom:
All people

Conditions:
If allowed, Shiraz University of Medical Sciences and authors are allowed to access

Where to obtain:
esmaeil Kargar. Contact number: 00989380676316
esmaeil.kargarda@gmail.com
Zahra molazem Associate Professor of Fatemeh Nursing and Midwifery Faculty
molazemzah@yahoo.com

How to obtain:
Contact authors email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Esmaeil Kargar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shiraz - Khalili Street Khalili Hospital</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۳۳۶ - ۷۱۳۴۸</zip>
        <telephone>+98 71 3629 1470</telephone>
        <email>esmaeil.kargarda@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Esmaeil Kargar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shiraz - Khalili Street Khalili Hospital</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۳۳۶ - ۷۱۳۴۸</zip>
        <telephone>+98 71 3629 1470</telephone>
        <email>Esmaeil.kargarda@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>People's willingness to participate in the study
Age range of 18 years old to 70 years old
Hospitalization for at least 1 day before surgery
No history of mental illness
No prohibition of non-steroidal anti-inflammatory drugs and analgesics
No addiction to drugs
The patient should have the ability of seeing and hearing
Patients who are candidates for single-eye vitrectomy surgery because of retinal detachment
The patients will be placed in group I or group II according to the physical state of ASA</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Inability to speak
Non-Iranian nationality
Any factor that leads the patient to become unresponsive after surgery
Having the history of attending anxiety control and problem-solving training classes</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Study group: After selecting the block, the allocation of patients to the study group is determined. On the night before the surgery, by considering the entry requirements of the study, and after having effective communication and gaining patient's trust, we will start to explain the process to the patient, gain his/her satisfaction and describe the research goals. Patient information is also recorded and the Spielberger questionnaire is filled in. Patients receive routine medical and nursing care according to the hospital policies. Afterward, some didactic photographs and videos will be shown to the patient by using a tablet, and his/her oral questions will be answered. The investigator explains to the patient about non-pharmacological pain control methods as the complementary of pharmacological therapies. In the next step, 30 minutes before entering the operating room, patient's information is recorded and the Spielberger questionnaire is filled in. All patients undergo the general anesthesia. After surgery, at intervals before entering the department, and 1, 2, 3, and 4 hours after entering the department, the level of pain and consumption of pain killers will be measured.</i_keyword>
      <i_keyword>Control group: After selecting the block, the allocation of patients to the control group will be determined. On the night before the operation, by considering the entry requirements of the study, after describing the process and gaining satisfaction of the patient, the patient's information will be recorded and the Spielberger questionnaire will be filled in. the control group's patients will receive routine medical and nursing care according to hospital policies. In the next step, 30 minutes before entering the operating room, patient's information is recorded and the Spielberger questionnaire is filled in. All patients undergo the general anesthesia. After surgery, at intervals before entering the department, and 1, 2, 3, and 4 hours after entering the department, the level of pain and consumption of pain killers will be measured.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety. Timepoint: The night before the operation and 30 minutes before entering the operating room. Method of measurement: Spielberger questionnaire.</prim_outcome>
      <prim_outcome>Pain. Timepoint: In the recovery room before entering the department; 1,2,3,4 hours after entering the department. Method of measurement: VAS.</prim_outcome>
      <prim_outcome>Consumption of analgesics. Timepoint: In the recovery room before entering the department; 1,2,3,4 hours after entering the department. Method of measurement: mg.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-06-02</approval_date>
        <contact_name>Ethics Committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Street Karim Khan Zand; Shiraz University of Medical Sciences Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
